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Abstract
Millions of pounds of polychlorinated biphenyl (PCB) compounds have been produced in multiple 
countries for industrial applications over the last several decades. PCB exposure induces various 
adverse health effects in animals and humans. Environmental and occupational exposures to PCBs 
have been associated with liver, kidney, endocrine, and neurodevelopmental adverse effects. We 
have collected and reviewed animal and human data cited in the U.S. National Library of 
Medicine from 2000–2010. In brief, our review shows new evidence that demonstrates:
In animal studies, exposure to one of the PCBs, A1221, induces a significant alteration of serum 
luteinizing hormone. The effects were more profound in the F2 generation, particularly with 
respect to fluctuations in hormones and reproductive tract tissues across the estrous cycle. 
Morphological analyses of brain tissue from rats exposed to A1254 confirmed earlier work that 
showed the relative size of the intra- and infra-pyramidal (II-P) mossy fibers was smaller than in 
controls, and reduction in growth was selective for the II-P mossy fibers. PCB exposure increased 
anogenital distance and prostate size but decreased epididymal weight, epididymal sperm count, 
and motile epididymal sperm count. No effects were observed on testicular weight or size.
The epidemiological data showed an association between diabetes mellitus prevalence and 
elevated concentrations of PCB-153. Additionally, prenatal PCB exposure studies were associated 
with a smaller thymic index at birth and could adversely affect immune responses to childhood 
vaccinations and resistance to respiratory infections. PCB exposure was also reported to adversely 
affect enamel development in children in a dose-dependent manner.
Because PCBs and their metabolites are potential health hazards, understanding the risk factors 
associated with individual PCBs, PCB mixtures, and PCB metabolites is important. PCB 
exposures of vulnerable populations (pregnant women, fetuses, infants, and children) are of 
particular concern because of heightened sensitivity during this period of brain development.
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Introduction
Polychlorinated biphenyls (PCBs) are a category of chemicals that were manufactured in the 
United States between about 1930 and 1977 (Hopf et al., 2009). Because of their general 
chemical inertness and heat stability, PCBs were predominantly used as coolants and 
lubricants in electrical equipment such as capacitors and transformers. Because of their non-
flammability, chemical stability, high boiling point, and electrical insulating properties, 
PCBs were used in hundreds of industrial and commercial applications including electrical, 
heat transfer, and hydraulic equipment; as plasticizers in paints, plastics, and rubber 
products; in pigments, dyes, and carbonless copy paper; and many other industrial 
applications (EPA 2014). Their high dielectric properties made them so useful.
PCBs were manufactured as a mixture of PCB congeners under a variety of names, the most 
common being Aroclor. Aroclor mixtures of chlorinated biphenyl congeners vary in degree 
of chlorination. One example is the commercial product Aroclor 1254, a mixture of mono- 
through hepta-chlorinated biphenyl congeners with an average chlorine content of 
approximately 54%. In 1977, the United States stopped the manufacture of PCBs after 
finding they accumulate and persist in the environment and can cause adverse health effects 
in humans and animals. No known consumer product currently manufactured in the United 
States contains PCBs, although some industrial processes still release them. Once 
commercial PCB mixtures are released into the environment, processes such as 
volatilization, partitioning, chemical or biological transformation, and preferential 
bioaccumulation alter them and dictate their environmental fate. These processes are 
dependent on the degree of chlorination of the biphenyl molecule (ATSDR 2000) (Figure 1). 
The higher chlorinated PCB congeners adsorb strongly to sediment and soil, where they tend 
to persist with half-lives of months to years.
PCBs also bioaccumulate in the food chain (Ivanciuc et al., 2006). Because of stability and 
lipophilicity, PCBs preferentially bioaccumulate in fatty tissues. Bioaccumulated PCBs 
persist in the body and are therefore of special relevance to human health. PCB exposure 
may occur as a result of ingesting contaminated food or inhaling contaminated air. However, 
food consumption has been and continues to be the major source of PCB exposure and thus, 
body burdens (Patandin et al., 1999). In 1978, the estimated dietary intake of PCBs for an 
average adult was about 0.03 μg/kg/day. By 1991, dietary intake had declined to <0.001 
μg/kg/day (ATSDR 2000). No current or systematic estimation of dietary intake of non-
dioxin-like PCBs in the U.S. is available, either on a total PCB basis or on the basis of 
individual PCB congeners (Aylward et al., 2014). However, Schecter et al. (2001) estimated 
mean daily TEQ intakes of dioxin and dioxin-like compounds of adult males and females to 
be 2.4 and 2.2 pg/kg/body weight, respectively. Evidence suggests that diets high in fish 
from PCB-contaminated waters, such as in the Great Lakes-St. Lawrence River basins, can 
significantly increase a person’s dietary PCB intake (Johnson et al., 1999). Breast-fed 
infants of mothers who have diets high in contaminated fish may have an increased risk for 
exposure resulting from PCB presence in breast milk (Lehmann et al., 2014). Human PCB 
exposure has also been attributed to inhalation of indoor air—especially at locations that still 
use electrical equipment containing PCBs (U.S. EPA 2012) Determination of body burdens 
of PCBs is a difficult process but can be accomplished by analytical measurement of PCBs 
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and their metabolites in organs and tissues. PCB exposure has mainly been assessed by 
measuring PCBs in blood, breast milk, and adipose tissue. Umbilical cord blood also has 
been used to estimate exposure in utero. When tissue and organ data are not available, 
exposure data can serve as a reasonable estimate of body burdens or adverse effect levels. 
Measurements of PCB levels in soil, sediment, air, food, and water have all been used to 
estimate human body burdens of PCBs. Of particular importance has been estimating fish 
consumption, particularly in contaminated areas and in subsistence fishing populations. For 
example, persons whose diets do not contain high levels of fish intake have serum PCB 
levels in the range of 0.9–1.5 ppb PCB. In populations with high fish intake (Greenlander), 
the mean concentration of total PCBs in omental fat samples was 5,719 μg/kg lipid basis 
(range=1,019–12,716 μg/kg lipid basis) (ATSDR 2000).
The human health assessment community uses the body burden and exposure information 
for PCBs to evaluate the public health impact of past, ongoing, and future exposures to 
PCBs. Our objective was to review the literature aiming to summarize and evaluate the 
current evidence of an association between PCBs and the exposure levels effects using the 
recently published literature included at the ATSDR Toxicological Profiles of PCBs 
Addenda, which provides to the public and other federal, state, and local agencies a non-peer 
reviewed supplement of scientific data published in the open peer-reviewed literature since 
the release of the profile.
General Population and Occupational Exposure
The general population may be exposed to PCBs from a variety of routes and sources, 
including diet, ambient air, occupational settings, and consumer products. Measurement of 
PCBs in biological samples generally reflects cumulative, prior exposures. The half-life of 
congeners varies from months to several years; congeners with few chlorine substitutions 
have shorter half-lives than the highly chlorinated congeners. Because highly chlorinated 
congeners are more slowly metabolized, they accumulate to higher levels. Thus, the profile 
of congeners detected in the environment may differ from the profile of the initially released 
PCBs. Exposure profiles may change over time also.
The major exposure route for humans is through food. Inhalation and dermal routes factor 
into occupational exposures in buildings containing PCBs, during PCB clean-up activities, in 
exposures at hazardous waste sites containing PCBs, and for swimmers in PCB-polluted 
waters. In all cases, total PCB levels must be based on specific congener analysis rather than 
in terms of commercial mixtures (Aroclors) because the congener patterns in environmental 
media and biological tissues usually do not match those in the parent Aroclors.
Cohort studies, community studies, and ongoing risk assessment activities at different sites 
in the United States have addressed how the environment will affect PCB body burden. 
Several published studies report levels of individual PCBs, total PCBs, hydroxylated PCB 
metabolites (OH-PCBs), total OH-PCBs, and mixtures of parents and metabolites. In 
general, the measured PCBs levels are comparable across studies; some examples include 
California mothers cohort (Park et al., 2009), East Chicago and Columbus Junction (Marek 
et al., 2013), Great Lakes cohort of pregnant African American women (McGraw and Waller 
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2009), The Adult Native American cohort (De Caprio et al., 2005), Hudson River 
communities (Fitzgerald et al. 2007, 2011), Anniston community (Silverstone et al., 2012, 
Goncharov et al., 2009), and the National Health and Nutrition Examination Survey 
(NHANES) (CDC 2009).
Indoor inhalation exposure with low chlorinated PCB congeners resulted in an increase of 
PCB 28 and PCB 52 blood levels in teachers working in a PCB-contaminated school 
(Schwenk et al., 2002). Accumulation of non-dioxin-like PCBs has been detected in several 
studies. Breastfeeding and consumption of fish from the Great Lakes contributed 
significantly to the increase of non-dioxin-like PCBs in the U.S. (Carpenter et al., 2005; 
Patterson et al., 1994; Turyk et al., 2006). The highest detection frequencies in the U.S. 
population were for PCBs 138, 153, and 180. These three congeners contributed 65% of 
total PCB body burdens (Needham et al. 2005). Generally, highly chlorinated PCB 
congeners (with 5, 6, or 7 chlorine atoms) contributed to 80% of the total PCBs in human 
serum. Comprehensive human serum analysis of coplanar, mono-ortho, and non-dioxin-like 
PCBs have been reported in the Fourth National Report on Human Exposures to 
Environmental Chemicals (CDC 2009).
The Centers for Disease Control and Prevention (CDC) publishes the National Report on 
Human Exposures to Environmental Chemicals, is an ongoing assessment of exposure to 
environmental chemicals in the general U.S. population. The Fourth Report contains data for 
years 1999–2000, 2001–2002, and 2003–2004, from participants in the National Health and 
Nutrition Examination Survey (NHANES). Detailed information on the design and conduct 
of NHANES is available at http://www.cdc.gov/nchs/nhanes/about_nhanes.htm. In general, 
the NHANES Fourth Report found that serum concentrations of PCBs reflected cumulative 
past exposure in the general U.S. population.
CDC measured polychlorinated biphenyls in serum from a random one-third subsample of 
participants aged 12 years and older in 1999–2000 and in 2003–2004. In 2001–2002, 
coplanar PCBs were measured in a random one-third subsample of participants aged 20 
years and older, while other PCBs were measured in a random one-third subsample of 
participants aged 12 years and older. Table 1 lists the dioxin-like PCBs (coplanar and mono-
ortho-substituted PCBs) and non-dioxin-like PCBs discussed in the Fourth Report. Included 
were the measured levels of 38 PCB congeners. Of these, six have previously documented 
animal and human health effects: PCB 118, PCB 126, PCB 138, PCB 153, PCB 170, and 
PCB 180.
Polychlorinated Biphenyls Health Effects
The following sections provide summaries of some of the scientific literature published 
since 2000 regarding the human and animal health effects of PCB exposure. Tables 2 and 3 
provide more detailed information about studies summarized in the text.
Systemic Effects
Jokinen et al.(2003) evaluated the effects of chronic exposure to dioxin (2,3,7,8,-
tetrachlorodibenzo-p-dioxin [TCDD]) and a dioxin-like compound (3,3′,4,4′,5-
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pentachlorobiphenyl [PCB-126]) on the cardiovascular system in female Harlan Sprague-
Dawley rats. Results indicated that the rat cardiovascular system was a target for dioxin and 
PCB-126 toxicity, based on increases in the incidence of spontaneous cardiomyopathy and 
arteritis of the coronary vessel. Lind et al. (2004) showed that female rats treated with 
PCB-126 had increased levels of serum cholesterol, increased blood pressure, and increased 
myocardial mass, all exposure-attributable. In the Lind et al. (2004) experiment, rats 
received a total dose of 224 μg/kg-bw in five intraperitoneal injections once every other 
week. The first two doses were 64 μg/kg-bw each, to attain a significant body burden 
rapidly. The remaining three doses were 32 μg/kg-bw each.
Effects on Bone Mineral Density (BMD)
Glynn et al. (2000) investigated the effect of PCB exposure on bone mineralization in 115 
Swedish men from the general population. Researchers observed no statistically significant 
relationship between PCBs exposure and bone mineral density (BMD). Wallin et al. (2004, 
2005) conducted similar studies, investigating the effects on bone in Swedish male and 
female adults. Although a weak association appeared between PCB-153 exposure and 
osteoporotic fractures, the relationship was not significant.
Weiss et al. (2006) reported similar findings. They assessed serum levels of the persistent 
PCB-153, hydroxylated polychlorinated biphenyl metabolites (OH-PCBs), polybrominated 
diphenyl ethers (PBDEs), and hexabromocyclododecanes (HBCDDs) in a group of Swedish 
middle-aged and elderly women. They found no association between BMD or the 
biochemical markers of bone metabolism and PCB-153 and PCB-hydroxylated metabolites. 
Still, the small number (184 women) of study participants limited the ability to detect any 
weak or moderate associations. Hodgson et al. (2008) conducted another study from a 
population 60–81 years of age (154 males, 167 females) living near the Baltic Coast. The 
results showed that the subjects (mainly males) who lived near a PCB-contaminated river 
and who were exposed to relatively low levels of PCB congeners had reduced BMD after 
controlling for major confounding variables. In males, PCB-118 (dioxin-like PCB) exposure 
was negatively associated with BMD: the odds ratio for low BMD (Z-score less than −1) 
was 1.06 (95% confidence interval, 1.01–1.12) per 10 pg/mL PCB-118. The sum of the three 
most abundant non-dioxin-like PCBs (PCB-138, PCB-153, PCB-180) was positively 
associated with BMD. In females, although PCB-118 was positively associated with BMD, 
this congener did not influence women’s low BMD risk.
Lundberg et al. (2006) studied the effects of perinatal exposure to PCB-153 and PCB-126 in 
female goat offspring. The goat dams were exposed to 98 μg/kg/day of PCB-153 or 49 
ng/kg/day of PCB-126 in corn oil on gestation day (GD) 60 until delivery. The offspring 
were also exposed to PCBs during the lactation period of 6 weeks. Diaphyseal bone was 
analyzed at a distance of 18%, and 50% of the total bone length and metaphyseal bone at a 
distance of 9%. Also, researchers conducted a biomechanical three-point bending of the 
bones, with the load applied to the mid-diaphyseal peripheral quantitative computed 
tomography (pQCT) measure point (50%). PCB-153 exposure significantly decreased the 
total cross-sectional area (125±4 mm2) versus non-exposed (142±5 mm2), decreased that of 
the marrow cavity (38±4 mm2) versus non-exposed (50±3 mm2), and decreased the moment 
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of resistance (318±10 mm3) versus non-exposed (371±20 mm3) at the diaphyseal 18% 
measure point. At the metaphyseal measure point, the trabecular bone mineral density 
(121±5 mg/cm3) was increased versus non-exposed (111±3 mg/cm3). PCB-126 exposure did 
not produce any observable changes in bone tissue. Researchers observed no significant 
changes in bone parameters in the PCB-126-exposed group. For either congener, the 
biomechanical testing showed no significant differences between the exposed and control 
groups.
Endocrine Effects
Rylander et al. (2005) measured serum PCB 153 concentrations in Swedish fishermen and 
their wives: 196 men (median age 60 years) and 184 women (median age 64 years). 
Participants answered questions about diabetes, medication, and disease onset. Elevated 
PCB-153 serum concentrations were significantly associated with diabetes mellitus type 2 
prevalence, even after adjustment for confounding variables. An increase of 100 ng 
PCB-53/g lipids was related to an odds ratio of 1.16 with 95% confidence interval (CI) 1.03–
1.32, p value= 0.03. This study suggested that PCB exposure was strongly related to 
prevalence of type 2 diabetes mellitus. Others also have reported associations between 
incidences of type 2 diabetes mellitus and exposure to PCBs (Vasiliu et al. 2006; Chen et al. 
2008; Codru et al. 2007; and Wang et al. 2005).
A cross-sectional study showed an association between diabetes mellitus prevalence and the 
concentrations of PCB-153 and p, p′-DDE in 544 serum samples among Swedish 
fishermen’s wives (Rignell-Hydborn et al. 2007). Lee et al. (2006, 2007a, b) reported similar 
findings, in which striking dose-response relationships appeared between serum 
concentrations of six selected persistent organic pollutants (POPs) and the prevalence of 
diabetes.
Turyk et al. (2009) conducted a study on a cohort of Great Lakes sport fish consumers. 
Established in 1990 and followed through 2005, this study investigated in the studied cohort 
the relationship between POPs, including several PCBs, body burdens, and the incidence of 
diabetes mellitus. Diabetes (Type 2) incident was not associated with mono-ortho PCB-118, 
total PCBs, or years of sport fish consumption.
Steinberg et al. (2008) administered to pregnant Sprague-Dawley rats 0, 0.1, 1, or 10 mg/kg 
Aroclor 1221 (A1221) on GD 16 and 18. With the low doses of A1221 given during this 
critical period of development on F1 and F2 female rats, litter sex ratio skewed toward 
females. In the F1 generation, additional effects were found, including a significant 
alteration of serum luteinizing hormone in the 1 mg/kg A1221 group. The F2 generation 
showed more profound alterations, particularly with respect to fluctuations in hormones and 
reproductive tract tissues across the estrous cycle.
Lilienthal et al. (2000) measured in rat dams and offspring the serum concentrations of 
vitamin D3 metabolites 25-hydroxycholecalciferol (25-D) and 1, 25-
dihydroxycholecalciferol (1, 25-D). Measurements occurred after exposure to a PCB 
mixture reconstituted according to the congener pattern found in human milk. The PCB 
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pattern in human breast milk has been reported elsewhere in the literature. Exposure of rat 
dams to the reconstituted PCB mixture at doses of 0, 5, 20, or 40 mg PCBs/kg diet caused 
dose-dependent reductions in their serum concentrations of 25-D during delivery but not at 
weaning. This effect was also seen for the two high-dose exposure levels in the offspring at 
birth and at weaning. In the offspring, there was also a PCB-induced decrease of 1, 25-D and 
25-D levels in the group exposed to the highest dosage of PCBs. The results demonstrate 
that exposure to a human milk-like PCB mixture leads to a decrease in concentrations of a 
hormone involved in calcium homeostasis.
Immunological and Lymphoreticular Effects
Park et al. (2008) examined the effects of prenatal exposure to PCBs on thymus size at birth 
in Eastern Slovakian neonates. Prenatal PCB exposure was associated with a smaller thymic 
index at birth [beta= −36 (natural log-transformed; nanograms per gram lipids); p = 0.047]. 
District of residence and delivery also predicted thymic index. Male sex, later gestational 
age, larger birth weight z-score, and Roma ethnicity were associated with a larger thymic 
index, whereas respiratory illness was associated with a lower thymic index (Park et al. 
2008). This evidence is the first to date suggesting that PCB exposure in neonates is 
associated with a smaller thymic volume, suggesting the possibility of impaired 
immunologic development.
In another study, Heilman et al. (2006) implied that PCB exposure was a possible cause of 
deficient immune function in children. They demonstrated that increased perinatal exposure 
to PCBs can adversely affect immune responses to childhood vaccinations. The study 
examined sera for antibody responses against diphtheria and tetanus vaccines from 119 
children at 18 months and 129 children at 7 years of age. The antibody response to 
diphtheria vaccine decreased at age 18 months by 24.4% (95% CI, 1.63–41.9; p=0.04) for 
each doubling of the PCB exposure at the time of examination. At age 7 years, antibody 
response to tetanus vaccine decreased by 16.5%. Langer et al. (2002) also evaluated the 
possible long-term effects of PCBs by comparing the prevalence of anti-glutamic acid 
decarboxylase antibodies (anti-GAD) with the development of diabetes mellitus. Although 
this retrospective study could not determine the prevalence of diabetes, the relationship 
between PCBs and the prevalence of anti-GAD antibodies supports the concept of an 
immunomodulatory effect of PCBs.
Neurological Effects
An occupational cohort study involving 17,321 workers indicated that exposure to PCBs 
likely has an effect on neurodegenerative diseases for women, but not for men. The total 
cohort showed no excess of neurodegenerative disease mortality compared with expectations 
in the U.S. population. Nevertheless, the data did show mortality excesses of amyotrophic 
lateral sclerosis (ALS, also known as motor neuron disease) among women and, in the high-
exposure group, of Parkinson disease and dementia (other than cerebrovascular dementia) 
among women (Steenland et al. 2006).
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Cromwell et al. (2007) examined the effect of PCBs on maternal odor conditioning in rat 
pups 12–14 days of age. PCB-77 exposure changed aspects of maternal-offspring interaction 
in these rodents. The results suggest that PCB exposure decreased the preference for the 
maternal-associated cue, but it did not impair discrimination for a novel odor. Pups exposed 
to perinatal PCBs did not remain in the cue-associated location longer relative to the noncue-
related location, nor did they remain longer for the lower (12.5 ppm) maternal PCB dose. 
The pups actually spent significantly longer time in the noncue location. These observed 
shifts in maternal cue preference were without significant changes in body weight, feeding, 
or olfactory function. Similarly, Cumming et al. (2005) reported that behavioral changes 
discerned through use of a cross-fostering paradigm suggested that maternal behavior 
changes were likely to emerge from direct effects of PCB-77 on the dams as well as in 
response to effects of the PCB on the litter.
Orito et al. (2007) exposed female rat dams orally at GD15 to 30 μg/kg/day of PCB-126 in 
corn oil. At 4–5 weeks of age, they assessed male offspring by use of an open field test. 
Intrauterine exposure to PCBs resulted in a reduction in time spent in the center of an open 
field, a reduction in the number of rearings, and an extension of grooming duration. 
Interaction behavior—an anxiety level index—was shortened in social interaction. The 
results suggest that exposure to PCBs may exert anxiogenic behavior in rats. The results of 
another study show that exposure to PCB-77 can have complex effects on behavioral 
interactions between dams and their litters, with a potential effect on offspring development 
(Cummings et al. 2005, 2008).
Moreover, exposure to PCB-77 during gestation and lactation can have a significant effect 
on the maternal behavior of rat dams, as reported by Simmons et al. (2005). Exposure to 2 
and 4 mg/kg of PCB-77 during GD 6–18 reduced the amount of nursing time in which the 
dams displayed high-crouch posture over postnatal days 1–6. The amount of maternal 
licking and grooming of the litters, the amount of time the dams spent on the nest, and pup 
mortality increased at the high dose. At both the higher and lower doses, the weight gain of 
the litters during the first 6 days of life was reduced.
Coburn et al. (2005) assessed the effect of PCBs on brain mechanisms of body fluid 
regulation. Particularly, they focused on both central and systemic vasopressin (VPs) release 
in response to acute dehydration after oral exposure to Aroclor 1254 in adult male rats. 
Central vasopressin release from magnocellular neuroendocrine cells in the supraoptic 
nucleus (SON) occurs within several hours after acute dehydration and is an important 
autoregulatory mechanism. SON from dehydrated PCB-naive rats released significantly 
more VP than did SON from control rats (4.9±0.8 vs. 2.7±0.4 pg/ml/μg of tissue weight). In 
contrast, PCB exposure had no effect on baseline water intake, weight gain, or plasma 
osmolality responses to dehydration in PCB-fed rats. But the SON failed to respond with 
increased VP release during dehydration. Dehydrated PCB-fed rats had an exaggerated 
increase in plasma VP. This finding indicates a limited inhibitory effect of central VP on 
plasma VP level.
In a study by Pruitt et al. (1999), rat pups were exposed to PCBs from conception to ages 16, 
30, or 60 days. They were then sacrificed and their brain tissues were stained with Timm’s 
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silver sulfide solution for mossy fiber in hippocampal tissue evaluation. Results from 
morphological analyses of brain tissue confirmed that in rats continuously treated with 
Aroclor 1254 at doses of 125 ppm, the relative size of the intra-and infra-pyramidal (II-P) 
mossy fiber was smaller than in control rats in all ages tested. Furthermore, this reduction in 
growth was selective for the II-P mossy fibers.
Dziennis et al. (2008) exposed rats to Aroclor 1254 (A1254) at 0.1 or 1 mg/kg/day in the 
maternal diet throughout gestation and lactation. Focal cerebral ischemia was induced at 6–8 
weeks of age via middle cerebral artery occlusion, and infarct size was measured in the 
cerebral cortex and striatum at 22 hr of reperfusion. PCB levels and cortical and striatal 
expression of Bc12 and Cyp2c11 were quantified in the brain by gas chromatography and 
quantitative reverse transcriptase-polymerase chain reaction, respectively. Exposure during 
the development period resulted in significantly decreased striatal infarct in females and 
males at 0.1 and 1 mg/kg/day, respectively. Effects of A1254 exposure during development 
on Bcl2 and Cyp2C11 expression did not correlate with effects on infarct volume.
Reproductive Effects
The associations of time to menopause and environmental exposure to PCBs and related 
compounds were assessed in Michigan women (n=874, age 24y and older) (Blanck et al. 
2004). During enrollment, between 1976 and 1978, the women provided serum PCBs 
samples. In 1997—19 years later—the women were interviewed about their menstrual 
periods, and PCBs were again measured in blood samples. Aroclor 1254 was measured with 
a level of detection of 5 ppb. The serum level of PCBs was divided into low (≤5 ppb), 
moderate (>5–11 ppb), and high (≥11 ppb) serum concentrations. No significant association 
between PCB levels and time to menopause was observed.
Gupta (2000) investigated the fetal long-term effect on the reproductive parameters of male 
mice offspring of pregnant mice fed 100 μg/kg/d of diethylstilbestrol (DES), 50 μg/kg/d of 
bisphenol A (BPA), and 50 μg/kg/d of Aroclor 1016 during GDs 16–18. The male offspring 
were examined at 3, 21, and 60 days after birth. The effects of PCB exposure were an 
increased anogenital distance, increased prostate size, and decreased epididymal weight. 
However, compared with controls, no effects were observed on testicular weight or size.
Pregnant rats were gavaged a single dose of 375 μg of PCB-118/kg body weight on GD 6 
(Kuriyama et al. 2004). This dose was 100-fold higher than that found in human tissue 
reported by WHO in 1996. The rat offspring were hyperactive at PND 70–74; at adulthood 
(PND 170), the exposure had adverse effects on the male reproductive system. Rat offspring 
had smaller testes, epididymides, and seminal vesicles; the offspring also had decreases in 
sperm and spermatid numbers and impairment of daily sperm production.
Hsu et al. (2007) treated pregnant rats with a single dose of PCB-132 at 1 or 10 mg/kg on 
GD15 and assessed male offspring at adulthood (PND 84). The adult male rats had a 
decrease in the cauda epididymus weight, epididymal sperm count, and motile epididymal 
sperm count. The spermatozoa of PCB-132-exposed offspring produced significantly higher 
levels of reactive oxygen species (ROS) than did the controls. In the 1 mg/kg dose group, 
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p53 was significantly induced and caspase-3 was inhibited, while in the 10 mg/kg dose 
group, activation of caspase-3 and -9 was significantly increased. At the same time, 
expressions were significantly decreased of Fas, Bax, bcl-2, and p53 genes.
Developmental Effects
In Finland, 34,457 infants born between 1997–2000 were examined for natal and neonatal 
teeth (Alaluusua et al. 2002). Exposure of the infants to 36 PCB congeners and other related 
contaminants was evaluated by measuring PCB congener levels in the children’s mothers’ 
milk samples when the children were 4–8 weeks old. The PCB median exposure level in 
milk was 7.24 picograms/gram (pg/g) in fat (measured as 2,3,7,8-TCDD toxicity 
equivalent). Thirty-four infants with teeth were observed (29 infants had one or two natal 
teeth, and five neonates had neonatal teeth). The prevalence of natal and neonatal teeth was 
1:1000. Therefore, no association was found between pollutant levels and occurrence of 
natal and neonatal teeth. This study suggested that PCB exposure levels in Finland were 
likely below the threshold to cause perinatal tooth eruption.
Jan and Vrdic (2000) and Jan et al. (2007) evaluated 432 Slovenian children 8–9 years of 
age for long-term PCB exposure. The total PCB serum concentrations in children were 
<200, 200–600, and >600 ng PCBs/g serum lipids. They used standard dental indices to 
evaluate caries susceptibility, gingival health, and enamel defects. The proportion of 
deciduous and permanent teeth affected with enamel defects was significantly higher in the 
highest exposed children (>600 ng PCB/g group). Compared with controls, caries 
susceptibility, gingival health, or number of teeth was not affected significantly. Still, a dose-
response relationship was observed between PCB exposure and developmental enamel 
defects of permanent teeth in children.
Brucker-Davis initiated a prospective case-control study of 151 cord bloods (67 
cryptorchid/84 matched control) and 125 colostrums (56 cryptorchid/69 matched control) to 
assess the incidence of cryptorchidism in male children exposed to PCBs during prenatal 
and postnatal life. Study results suggested a positive association (p=0.045) between high 
total PCB concentrations (perinatal exposure) and cryptorchidism in boys.
Patterson et al. (2009) studied a randomly selected cohort of 615 children from 12 U.S. 
study centers born during 1959–1965. A complete data set was available for 195 children 
with sensorineural hearing loss. Exposures to PCBs were measured as total PCB 
concentration in maternal serum, with the median measured as 2.8 μg/L during the third 
trimester. This level was about twofold higher than in recent background levels in the U.S. 
The geometric mean PCB concentration in whole blood for the 2003–2004 NHANES 12-
year and older study population was 0.820 ppb (ng/g). Longnecker et al. (2004) evaluated 
hearing when the children were about 8 years old, observing no significant adverse effects 
on the average hearing threshold across the frequencies required for speech recognition.
Riva et al. (2004) established a prospective cohort study for randomly selected children who 
breastfed exclusively for at least 4 months—25 of 353 healthy, full-term children who were 
born between April and June of 2000. Levels of PCB congeners (PCBs 105, 118, 138, 153, 
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156, and 180) were measured in colostrum and breast milk at 1 and 3 months after delivery. 
Visual function evaluations were carried out by P100. (The major component of the visual 
evoked potentials [VEP] is the large positive wave peaking at about 100 milliseconds [also 
called P100]). The P100 is very reliable and stable between individuals from 5 to 60 years of 
age, with latency visual evoked potentials (VEPs) being measured starting at 12 months of 
age. At 15 months of age, impaired VEP was significantly correlated (r=0.401–0.618) with 
all PCB congeners except for PCB-105. But VEP at 1 hour correlated (r=0.504) with 
PCB-180 only. This study suggests a weak correlation at 12 months of age between PCB 
levels and impaired visual functions.
Wang et al. (2005) selected pregnant women (n=118, age 25–34 years of age) to participate 
in a study to examine the association between transplacental exposure to dioxins/PCBs and 
thyroid and growth hormones in newborns. Cord sera from 118 newborns were analyzed for 
12 dioxin-like PCB congeners, for other related compounds such as dioxins, and for thyroid 
and growth hormones. Statistical analyses showed independently and significantly decreased 
concentrations of free T4 (FT4) x TSH with increasing non-ortho PCBs (r = −0.2; p < 0.05). 
Differences in compositions and exposure levels to PCBs might result in different health 
effects.
Cao et al. (2008) recruited a cohort of 232 pregnant German women 18–42 years of age for a 
2000–2002 study. The authors investigated PCB and dioxin effects on gonadal hormones. 
Maternal blood and milk samples were collected from a subset of 104 mother-infant pairs 
for chemical analyses of Σ6 PCBs (28, 52, 101, 138, 153, and 180) as indicator PCBs and of 
17 PCDD/F congeners. The median concentrations in maternal blood fat and milk fat for the 
sum of the indicator PCBs (28, 52, 101, 138, 153, and 180) were 149 and 177 ng/g. The 
median concentrations of PCDD/F in maternal blood fat and milk fat were 15.3 and 13.1 pg 
WHO-TEQs/, respectively.
Cao et al. (2008) analyzed maternal sera and cord sera for testosterone and estradiol. In girls, 
the adjusted means ratio (MR) for testosterone hormonal level in cord serum samples was 
significantly reduced (MR = 0.81, 95% CL 0.69–0.94 for Σ non-o-PCBs; MR = 0.72, 95% 
CL 0.57–0.90 for Σ mono-o-PCBs; MR = 0.76, 95% CL 0.61–0.96 for Σ6 PCBs; MR = 0.69, 
95% CL 0.53–0.90 for ΣPCDD/F)—but not in boys. On other hand, after PCB exposures 
estradiol levels were significantly reduced in boys but not in girls. Estradiol levels were not 
significantly associated with any PCB category level. This study suggested that even low 
levels of PCBs had a robust negative effect on gonadal hormones in newborns.
Another study, however, found no strong association between umbilical cord PCB levels and 
testicular sizes, serum testosterone concentrations, or spermaturia in boys at 7 and 14 years 
of age (Mol et al. 2002).
Denham et al. (2005) studied a cohort of 138 girls (10–16.9 years old) from the Akwesasne 
Mohawk Nation, New York, who had been exposed to PCBs via food. They compared blood 
PCB levels against attainment of menses. More than 50% of the blood samples contained 16 
PCB congeners. In this study, the presence or absence of menses at the time of the interview 
was recorded. The geometric mean (0.12 ppb) of estrogenic PCBs (PCB 52, 70, 90/101, 
Faroon and Ruiz Page 11
Toxicol Ind Health. Author manuscript; available in PMC 2016 December 08.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
187) was associated with a significantly greater probability of having started menarche early 
(β=2.12). Among 12-year-old girls, 86% were predicted to have reached menarche at the 
75th percentile of estrogenic PCBs levels. The study suggested that even at low levels of 
estrogenic PCBs, the time to menarche attainment decreased. The median age at menarche 
for this cohort (138 girls) was 12.2 years. But Vasiliu et al. (2004) reported no association 
with maternal PCBs exposure. The serum concentrations of PCBs 138, 153, and 180 and 
other related contaminants were measured in 200 persons who lived in high-, moderate-, 
low-, or non-contaminated areas, with a mean age of 17.4 years. In boys, the testicular 
volumes and pubic hair growth were measured. In girls, the adult stage of breast 
development was measured. In the highest contaminated areas, significantly fewer boys 
reached the adult stage of genital and pubic hair development, in comparison with controls. 
In the highest contaminated areas, fewer girls reached the adult stage of breast development. 
The present study indicated that exposure to certain PCB congeners may interfere with 
human reproductive development (Den Hond et al. 2002).
Meerts et al. (2004) investigated developmental effects of in-utero exposure to 4-
hydroxy-2,3,3′,4′,5-pentachlorobiphenyl (4-OH-PCB107). They focused on rat sex-steroid 
hormone levels and female reproduction. The developmental effects observed following 
exposure to 4-OH-PCB 107 were a dose-related prolongation of the estrous cycle in female 
offspring, measured between PNDs 210 and 231 and increased estradiol progesterone ratios. 
The effects of 4-OH-PCB 107 were considered sex-related—at PNDs 310 to 325, no effects 
could be detected on male accessory sex organ weights or testosterone levels.
Kobayashi et al. (2008) exposed Sprague-Dawley rat dams to PCB-153 (0, 16, or 64 mg/kg/
day) orally from GD 10 through GD 16. At age 1 or 3 weeks, the male and female offspring 
were examined for changes in developmental parameters. Changes were dose-dependent in 
body weight, body length, tail length, and weights of kidneys, testes, ovaries, and uterus. A 
significant dose-dependent decrease occurred in plasma concentrations of thyroxine (T4) 
and tri-iodothyronine (T3). But no changes occurred in any dose group in plasma 
concentrations of growth hormone and insulin-like growth factor-1.
Gupta (2000) fed pregnant Charles River rats 50 μg/kg/day of Aroclor 1016 dissolved in 
corn oil at GD 16–18. Compared with control, Aroclor 1016 increased anogenital distance, 
increased prostate size, and decreased epididymal weight. No effects were found on 
testicular weight or size in offspring.
Steinberg et al. (2007) exposed pregnant female rats by IP injection to low levels of Aroclor 
1221 (0, 0.1, 1, or 10 mg/kg) on embryonic day 16 of F1. The exposure of offspring to 
Aroclor 1221 resulted in a significant reduction in their mating-trial pacing, vocalizations, 
ambulation, and the female’s likelihood to mate. Shirota et al. (2006) reported similar results 
in the reproductive developmental effects of female rats exposed to PCB 126.
Lyche et al. (2004) examined the possible adverse effects on the hypothalamic-pituitary-
gonadal axis. They measured gonadotrophins and gonadal steroid hormone concentrations in 
goat offspring exposed during gestation and lactation to environmental doses of PCB-153 
and PCB-126. The doses of PCBs 153 and 126 were estimated at 98 μg/kg/day and 0.049 
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μg/kg/day, respectively. The results indicated that maternal exposure to low doses of PCB 
153 during gestation and lactation suppressed prepubertal plasma luteinizing hormone 
concentrations and delayed the onset of female offspring puberty. PCB 126 did not produce 
any observed effects at the exposure level tested in this study. The resulting concentrations in 
adipose tissue 9 months post-partum in the goat offspring were 5.8 μg/g (fat weight) and 
0.00049 μg/g (fat weight) for PCBs 153 and 126, respectively.
Crofton et al. (2000) compared the effect of prenatal versus postnatal rat exposure to Aroclor 
1254. In this study, primiparous rats received 0 or 6 mg/kg A1254 (po in corn oil) from GD 
6 to PND 21. On the day of birth, half of treated litters and half of the control litters were 
cross-fostered. As a result, the experiment consisted of the following groups: Ctrl/Ctrl, 
A1254/A1254 (perinatal exposure), A1254/Ctrl (prenatal exposure only), and Ctrl/A1254 
(postnatal exposure only). Serum thyroid hormone concentrations were assessed, as were 
liver and brain concentration of PCBs, body weight, mortality, and age at eye opening, 
auditory startle amplitudes, and auditory thresholds for 1 kHz and 40 kHz tones. The results 
demonstrated that postnatal exposure alone was responsible for ototoxicity. These cross-
fostering experiments also showed that prenatal-only exposure led to small postnatal 
hypothyroxinemia, which recovered by the end of lactation. But the hypothyroxinemia that 
occurred following postnatal-only exposure matched that seen with perinatal exposure 
within a few days after birth.
Kenet et al. (2007) exposed pregnant rats orally to non-coplanar PCBs (6 mg/kg/day of 
PCB-95) during the gestational period and throughout 3 subsequent suckling weeks. 
Exposure to non-coplanar PCBs resulted in abnormal development of the primary auditory 
cortex in pups. Still, the pups’ hearing sensitivity and brainstem auditory responses were 
normal.
Cancer
In a population-based case-control study in the United States, De Roos et al. (2005) 
investigated how exposure to PCBs and to other organochlorines might affect the risk of 
non-Hodgkin’s lymphoma. Certain PCB congeners, particularly the higher chlorinated PCBs 
(PCB 156,180,194) were associated with increased risk of non-Hodgkin’s lymphoma 
development, with odds ratios for the highest versus lowest quartile ranging from 2.7 to 3.5, 
and significant trends (p<0.05) across categories.
Hardell et al. (2004) found that PCB blood concentrations were higher in mothers of patients 
with testicular cancer than in controls—a finding that supported the hypothesis regarding the 
fetal etiology of testicular cancer (Hardell et al. 2003).
Hardell et al. (2006) reported an association between persistent organophosphate pollutants 
(POPs) and prostate cancer, significantly so for PCB 153 in the total study population of 58 
cases. Of the 38 PCB congeners studied, PCB-153 had the highest adipose tissue 
concentration. For most of the studied POPs, OR increased further in the case group with 
PSA greater than 16.5 ng/mL. Similar studies suggested that long-term, low-dose exposure 
to specific organochlorine pesticides and PCBs in the general population may contribute to 
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an increased risk of prostate cancer; those studies also recommended further investigation 
(Ritchie et al. 2003, 2005).
Nyska et al. (2004) evaluated the effects of chronic exposure to dioxin and multiple dioxin-
like PCBs on the pancreas of the female Harlan Sprague-Dawley rat. Animals were treated 
with PCB-126 by gavage for up to 2 years. The specific dose used in the TEF mixture study 
was 33.3 ng/kg PCB-126. The study indicated that the pancreatic exocrine acini represented 
a target tissue of the PCB-126, inducing mainly degenerative, inflammatory, and atrophic 
lesions and possibly also sporadic acinar adenomas and carcinomas.
Exposure by gavage of female Harlan Sprague–Dawley rats to PCB-126 at doses of 0, 30, 
100, 175, 550, and 1,000 ng/kg/day—assuming a PCB-126 TEF of 0.1 for up to 2 years—
resulted in a dose-related increase in the incidence of bronchiolar metaplasia of the alveolar 
epithelium, as reported by Brix et al. (2004). Exposure to PCB-126 increased the incidences 
and severity of neoplastic and nonneoplastic lesions in the lung.
Groups of Harlan Sprague-Dawley rats were treated by gavage with PCB-153 in corn oil 
acetone: (99:1) at doses of 10, 100, 300, 100, or 3,000 μg/kg 5 days/week for up to 105 
weeks. Exposure at the highest dose (3,000 μg/kg) continued for 30 weeks. Treatment then 
changed to vehicle only for the rest of the study. This 2-year gavage study found equivocal 
evidence of carcinogenic activity of PCB-153 in female Harlan Sprague-Dawley rats; the 
evidence was based on the occurrence of cholangioma of the liver. PCB-153 administration 
caused increased incidences of nonneoplastic lesions of the liver, thyroid gland, ovary, 
oviduct, and uterus in female rats (NTP 2006a).
Groups of 81 female Harlan Sprague-Dawley rats were treated by gavage with PCB-126 in 
corn oil: acetone (99:1) at doses of 30, 100, 175, 300, 550, or 1,000 ng/kg 5 days/week for 
up 104 weeks. Another 50 female rats were exposed to the highest dose (1,000 μg/kg) for 30 
weeks and then only to vehicle for the rest of the study. This 2-year oral gavage study 
revealed clear evidence of carcinogenic activity of PCB-126 in female Harlan Sprague-
Dawley rats on the basis of increased incidences of cholangiocarcinoma of the liver, 
squamous neoplasms of the lung (cystic keratinizing epithelioma and squamous cell 
carcinoma), and gingival squamous cell carcinoma of the oral mucosa. Administration of 
PCB-126 was also possibly associated with hepatocellular adenoma and hepatocholangioma 
of the liver. Neoplasms of the adrenal cortex and cholangioma of the liver may have been 
related to administration of PCB-126 (NTP 2006b). In female rats, the administration of 
PCB-126 by oral gavage for 2 years produced an increased incidence of nonneoplastic 
lesions of the liver, lung, adrenal cortex, pancreas, kidney, heart, thyroid gland, thymus, 
spleen, clitoral gland, and mesenteric artery (NTP 2006b).
Another 2-year oral gavage NTP study showed clear evidence of carcinogenic activity of a 
constant ratio binary mixture of PCB-126 and PCB-153 in female Harlan Sprague-Dawley 
rats. The daily doses were 10, 100, 300, or 1,000 ng of PCB-126, each with 1,000 times 
more PCB-153, per kilogram body weight. The evidence was based on increased incidences 
of cholangiocarcinoma, hepatocholangioma, and hepatocellular neoplasms (predominantly 
adenomas) of the liver, squamous neoplasms of the lung (predominantly cystic keratinizing 
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epithelioma), and gingival squamous cell carcinoma of the oral mucosa. Increased 
incidences of pancreatic acinar neoplasms were also possibly related to the administration of 
the binary mixture of PCB-126 and PCB153. The increased incidences of uterine squamous 
cell carcinoma may have been related to administration of the binary mixture of PCB-126 
and PCB-153. The uterine squamous cell carcinoma is rare type of cancer. Administration of 
the binary mixture of PCB-126 and PCB-153 caused increased incidences of nonneoplastic 
lesions in the liver, lung, oral mucosa, pancreas, adrenal cortex, thyroid gland, thymus, 
kidney, nose, and forestomach (NTP 2006c). In a 2-year oral gavage study, similar results of 
carcinogenic activity were found for the binary mixture of PCB-126 and PCB-118 (NTP 
2006d).
In another 2-year oral gavage study, female rats were exposed to ratios of 1 part TCDD, 2 
parts PeCDF, and 10 parts PCB-126. The dose formulation was intended to give 
approximately equal toxic contributions from each substance. The administered doses were 
10, 22, 46, or 100 ng toxic equivalents/kg body weight in corn oil: acetone (99:1) by gavage 
daily for 5 days/week for up to 105 weeks. In female Harlan Sprague-Dawley rats, clear 
evidence of carcinogenic activity appeared for the mixture of TCDD, PeCDF, and PCB-126. 
The evidence was based on increased incidences of hepatocellular adenoma and 
cholangiocarcinoma of the liver and cystic keratinizing epithelioma of the lung. Neoplasms 
of the pancreatic acinus may have been related to administration of this mixture. This cancer 
is rare, forming only 1% of all pancreatic tumors. In this case, cancer arises from acinar cells 
of the pancreas and secretes pancreatic enzymes, mostly lipase. Also, in female rats this 
mixture caused increased incidences of nonneoplastic lesions of the liver, lung, pancreas, 
adrenal cortex, oral mucosa, uterus, thymus, ovary, kidney, heart, bone marrow, urinary 
bladder, mesenteric artery, and thyroid gland (NTP 2006e). Table 2 and 3 contain summaries 
of recent epidemiologic studies of human exposures to PCBs, and animal studies, 
respectively.
Conclusion
Biomedical data from human and laboratory and mammal studies provide evidence of PCB 
exposure’s toxic potential. Information on health effects of PCBs is available from studies of 
people who
• Were exposed in the workplace,
• Consumed contaminated fish, and
• Were exposed to environmental levels.
As summarized in this article, recent advances in the study of PCBs effects have associated 
exposure to PCBs in humans, in animals, or in both with
• Endocrine changes,
• Dental changes,
• Immunological alterations,
• Neurodevelopmental and reproductive changes, and
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• Cancer.
The human studies of occupational exposure, contaminated fish consumption, and general 
populations are complicated by the mixture-nature of PCB exposure and possible 
interactions between congeneric components and other chemicals. Although PCBs may have 
contributed to adverse health effects in these human populations, which congeners may have 
caused the effects cannot be determined with certainty. That said, however, animal studies 
have shown that PCBs induce effects in non-human primates at lower doses than in other 
species. Immunological, dermal/ocular, and neurobehavioral changes have been shown to be 
particularly sensitive indicators of toxicity in non-human primates exposed either as adults, 
or during pre- or postnatal periods.
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Figure 1. 
Chemical structure of Polychlorinated Biphenyls (PCBs)
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Table 1
Coplanar, Mono-ortho and Non-Dioxin-like Polychlorinated Biphenyls (PCBS) from the Fourth National 
Report on Human Exposure to Environmental Chemicals.
Coplanar PCBs Geometric Mean‡ 50th Percentile 75th Percentile 95th Percentile
3,4,4′,5-Tetrachlorobiphenyl (PCB 81) * < LOD < LOD 13.4
3,3′,4,4′,5-Pentachlorobiphenyl (PCB 126) 16.3 14.7 24.8 68.7
3,3′,4,4′,5,5′-Hexachlorobiphenyl (PCB 169) * < LOD 19.5 40.6
Mono-ortho-PCBs
2,3,3′,4,4′-Pentachlorobiphenyl (PCB 105) 1.20 1.09 1.90 6.24
2,3′,4,4′,5-Pentachlorobiphenyl (PCB 118) 6.00 5.19 10.4 31.3
2,3,3′,4,4′,5-Hexachlorobiphenyl (PCB 156) 2.54 3.29 7.00 15.3
2,3,3′,4,4′,5′-Hexachlorobiphenyl (PCB 157) 0.605 0.80 1.73 3.80
2,3′,4,4′,5,5′-Hexachlorobiphenyl (PCB 167) 0.494 0.70 1.60 4.10
2,3,3′,4,4′,5,5′-Heptachlorobiphenyl (PCB 189) * < LOD < LOD 1.47
Non-dioxin-like PCBs
2,4,4′-Trichlorobiphenyl (PCB 28) 4.90 4.96 6.79 11.3
2,2′,3,5′-Tetrachlorobiphenyl (PCB 44) 2.06 2.05 3.03 5.70
2,2′,4,5′-Tetrachlorobiphenyl (PCB 49) 1.29 1.35 1.90 3.53
2,2′,5,5′-Tetrachlorobiphenyl (PCB 52) 2.66 2.74 4.17 7.60
2,3′,4,4′-Tetrachlorobiphenyl (PCB 66) 1.39 1.37 1.97 4.10
2,4,4′,5-Tetrachlorobiphenyl (PCB 74) 4.81 4.36 8.72 22.3
2,2′,3,4,5′-Pentachlorobiphenyl (PCB 87) 0.656 0.90 1.32 2.70
2,2′,4,4′,5-Pentachlorobiphenyl (PCB 99) 4.16 3.79 6.53 18
2,2′,4,5,5′-Pentachlorobiphenyl (PCB 101) 1.65 1.7 2.70 5.83
2,3,3′,4′,6-Pentachlorobiphenyl (PCB 110) 1.22 1.20 1.96 4.42
2,2′,3,3′,4,4′-Hexachlorobiphenyl (PCB 128) * < LOD < LOD 0.60
2,2′,3,4,4′,5′-Hexachlorobiphenyl (PCB 138) & 2,3,3′,4,4′,6-
Hexachlorobiphenyl (PCB 158)
15.1 15.1 30.5 75.3
2,2′,3,4′,5,5′-Hexachlorobiphenyl (PCB 146) 2.17 2.21 4.80 11.7
2,2′,3,4′,5′,6-Hexachlorobiphenyl (PCB 149) 0.598 0.60 0.90 1.90
2,2′,3,5,5′,6-Hexachlorobiphenyl (PCB 151) * < LOD 0.42 1.00
2,2′,4,4′,5,5′-Hexachlorobiphenyl (PCB 153) 19.8 20.8 43.3 97.1
2,2′,3,3′,4,4′,5-Heptachlorobiphenyl (PCB 170) 5.46 6.30 12.9 28.2
2,2′,3,3′,4,5,5′-Heptachlorobiphenyl (PCB 172) 0.647 0.90 1.80 4.16
2,2′,3,3′,4,5′,6′-Heptachlorobiphenyl (PCB 177) 1.13 1.30 2.77 7.20
2,2′,3,3′,5,5′,6-Heptachlorobiphenyl (PCB 178) 0.933 1.20 2.50 6.10
2,2′,3,4,4′,5,5′-Heptachlorobiphenyl (PCB 180) 15.1 18.0 37.1 81.5
2,2′,3,4,4′,5′,6-Heptachlorobiphenyl (PCB 183) 1.45 1.60 3.29 7.90
2,2′,3,4′,5,5′,6-Heptachlorobiphenyl (PCB 187) 4.23 4.60 10.1 24.3
2,2′,3,3′,4,4′,5,5′-Octachlorobiphenyl (PCB 194) 2.69 4.19 8.47 19.1
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Coplanar PCBs Geometric Mean‡ 50th Percentile 75th Percentile 95th Percentile
2,2′,3,3′,4,4′,5,6-Octachlorobiphenyl (PCB 195) * 0.90 1.98 4.51
2,2′,3,3′,4,5,5′,6′-Octachlorobiphenyl (PCB 199) 2.81 3.80 8.30 18.9
2,2′,3,3′,4,4′,5,6′-Octachlorobiphenyl (PCB 196) & 2,2′,
3,4,4′,5,5′,6-Octachlorobiphenyl (PCB 203)
2.61 3.40 6.70 15.0
2,2′,3,3′,4,4′,5,5′,6-Nonachlorobiphenyl (PCB 206) 2.13 2.34 5.00 13.7
2,2′3,3′4,4′5,5′6,6′-Decachlorobiphenyl (PCB 209) 1.40 1.18 3.20 11.1
*
not calculated; LOD: Limit of detection (0.4).
‡Concentration units (ng/g of lipid)
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 ro
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 o
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